LEXURE for Post-Stroke Aphasia

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 116 participants.

Also called NCT07570264

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 116 participants (planned count) (from the registry)
Sponsor
Nunaps Inc (from the registry)
Registry
  • NCT NCT07570264
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07570264. Randomized; single masking; primary purpose treatment. Start 2026-04-16 (actual); primary completion 2026-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
LEXURE for Post-Stroke Aphasia
Condition
Aphasia
Intervention (Device)
LEXURE
Intervention (Behavioral)
Workbook
Lead sponsor
Nunaps Inc (class: industry)

Record details

Record id
cardio:ct-nct07570264
Content hash
9d594d705f82c35974878c2aaabe4ec769c9acce88f602abeaf13334861531ef